70121-1571 RELEUKO - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

70121-1571

Brand Name:

RELEUKO

Generic Name:

Filgrastim

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: FILGRASTIM

Strength: 480.0

Unit: ug/1.6mL

Packages:

Code: 70121-1571-07

Description: 10 VIAL in 1 PACKAGE (70121-1571-7) / 1.6 mL in 1 VIAL

Effective Date: Feb. 25, 2022

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Immunostimulant

Minor Class:

Granulocyte Colony-Stimulating Factor

Orphan Drug Designation:

Status:

In Use